Global Liver Institute
GLOBAL LIVER INSTITUTE
If you are living with liver disease, have received a liver transplant or are immunosuppressed, you are at high risk for COVID-19.
GLI developed the COVID-19 Response Program for Liver Patients to provide timely medical updates, informational articles, and policy recommendations.
Medical Updates for Liver Patients
Updated AASLD COVID-19 Expert Consensus Statement (as of October 6, 2021): “Vaccines to Prevent COVID-19 Infection in Patients with Liver Disease”
Updated AASLD COVID-19 Vaccine Document Supplemental Materials (as of August 30, 2021): “Non-COVID-19 Vaccines in Patients with Chronic Liver Disease”